Topic

Articles

Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.

Synthego Aims to Accelerate Drug Discovery with New Engineered Cell Libraries

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Merck Digital Sciences Studio Supports Early-Stage Startups

Feliza Mirasol is the science editor for 

Advances in genomics tools can lead to quicker biotherapeutic development.

Employing Genomics Tools to Accelerate Drug Development

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

Thermo Fisher Scientific Extends Collaboration Support for Biopharma Discovery and Development

GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.

GSK and University of Oxford Partner on Disease Research to Advance Drug Discovery and Development

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Can Vaccine Development Be Safely Accelerated?

The strategic alliance provides an integrated product offering around drug discovery and development.

PMI Biopharma Solutions, Nashville Biosciences Partner on Comprehensive Drug Discovery

Experts explore the role gene-editing techniques can play in regenerative medicine and cell-line development.

Gene-Editing Techniques Target New Applications

In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.

Gilead, AbCellera in Therapeutic Antibody Discovery Collaboration

Researchers at the University of Sheffield, Sheffield, UK, have discovered and developed a new compound that can kill antibiotic-resistant bacteria, including Escherichia coli.

Discovery Pipeline